Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image5th August 2024 Vol. No. 13 ; Issue No.642
Publications

1. Joshi R, Goswami D, Saha P, Hole A, Mandhare P, Wadke R, Murthy P, Borgohain S, CM Krishna, Kapoor S (2024). Serum Raman spectroscopy: Unearthing the snapshot of distinct metabolic profile in patients with Congenital Heart Defects (CHDs). Heliyon.

2. Joshi P, Bavaskar M, Shetty R, Singh A, Nair S, Chaturvedi P (2024). Local flap reconstructions in oral cavity defects: An insight from 104 Cases. Rambam Maimonides Medical Journal. 15(3): e0012.

Site of the Week

GlycanMass is a tool which allows to calculate the mass of an oligosaccharide structure.

desktop Image
Interesting Reads

Wang X, Zhao H, Luo X, Chen Y, Shi C, Wang Y, Bai J, Shao Z, Shang Z (2024). NNMT switches the proangiogenic phenotype of cancer-associated fibroblasts via epigenetically regulating ETS2/VEGFA axis. Oncogene.

Video of the Week
Optimizing the Identification of HER2-Low Breast Cancer
Upcoming Events
TMC HEAD & NECK REHABCON 2024 (Tata Memorial Centre Rehabilitation Conference)

31st August, 2024

At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai

1st Genomic Workshop on Next Generation Sequencing and Bioinformatics

24- 28th September 2024,

At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai

12th International Confernece of Laboratory Animal Scientists' Association (LASA), India

Pre Conference Workshop November 28, 2024 Conference 29-30th November 2024

At ACTREC, Tata Memorial Cetre, Kharghar, Navi Mumbai & CIDCO Convention Centre, Vashi, Navi Mumbai

Do You Know?

In 1970, Leonard Herzenberg developed the flourescence-activated cell sorter, revolutionizing the study of cancer cells.

back Image
Cancer News
Researchers develop promising therapy treatment that can kill glioblastoma cells in newly-discovered brain pathway.

MedicalXpress, 02/08/2024

To discover the pathway cancer cells use to infiltrate the brain, researchers used large-scale gene editing technology to compare gene dependencies in glioblastoma when it was initially diagnosed and after it returned following standard treatments...

Nimotuzumab can significantly increase the chances of survival in head and neck cancer, Tata Memorial study finds.

The Financial Express, 31/07/2024

According to the results of the Phase III study on 536 patients, Nimotuzumab not only improves progression-free survival but also maintains a good quality of life for long-term survivors, making it a potential therapeutic choice for this disease in India...

Department of Atomic Energy inaugurates ‘One DAE One Subscription’.

Press Information Bureau, 29/07/2024

The inaugural ceremony of ‘One DAE One Subscription’ (ODOS) took place at Tata Memorial Hospital, Mumbai. ODOS is a unique idea enabling Department of Atomic Energy (DAE) & all its units/subunits (about 60) together under one umbrella for read and publish access...

2024 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)